mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.1 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |